• MeSH
• Faculty, Medical MeSH
• Disease physiopathology   MeSH
• Pathology MeSH
• Education, Medical MeSH
• Teaching methods   MeSH

• MeSH
• Radiotherapy Dosage MeSH
• Carcinoma radiotherapy   MeSH
• Humans MeSH
• Prostatic Neoplasms radiotherapy   MeSH
• Radiotherapy methods   MeSH
• Check Tag
• Humans MeSH
• Male MeSH

• MeSH
• Administration, Topical MeSH
• Hydrocortisone administration & dosage   therapeutic use   MeSH
• Humans MeSH
• Urea MeSH
• Polycyclic Aromatic Hydrocarbons administration & dosage   therapeutic use   MeSH
• Psoriasis drug therapy   MeSH
• In Vitro Techniques MeSH
• Triamcinolone administration & dosage   therapeutic use   MeSH
• Check Tag
• Humans MeSH

• MeSH
• Energy Metabolism MeSH
• Myocardial Infarction prevention & control   etiology   MeSH
• Coronary Disease prevention & control   etiology   MeSH
• Myocardium metabolism   MeSH
• Publication type
• Congress MeSH

• Conspectus
• Patologie. Klinická medicína
• NML Fields
• kardiologie
• angiologie

• MeSH
• Absorption MeSH
• Activation Analysis MeSH
• Radiometry MeSH
• In Vitro Techniques MeSH

• MeSH
• Bacteria growth & development   MeSH
• Cellulose MeSH
• Fermentation MeSH
• Plants, Edible MeSH
• Culture Media MeSH
• Mathematics methods   MeSH

• MeSH
• Electroencephalography MeSH
• Rats MeSH
• Humans MeSH
• Brain physiology   MeSH
• Animals MeSH
• Check Tag
• Rats MeSH
• Humans MeSH
• Animals MeSH

• MeSH
• Biological Products MeSH
• Health Care Economics and Organizations MeSH
• Culture Media MeSH

Nadvou očníchklinikách v České republice bylo léčeno v letech 1999-2001 osmnáct pacientů trpících retinoblastomem, přičemž u čtyř pacientů se jednalo o bilaterální postižení. Šest bulbů, vzhledem k pokročilosti onemocnění, bylo primárně enukleováno, zbylý počet (šestnáct) byl léčen chemoredukcí a lokálními terapeutickými metodami v různé kombinaci podle konkrétního nálezu. Devět bulbů z tohoto počtu bylo v různémčasovém odstupu od zahájení léčby enukleováno pro recidivu onemocnění, jeho pokračování nebo pro komplikace léčby. Nádorový proces ve zbývajících sedmi bulbech nejeví známky aktivity. Frakcionovaná radioterapie byla využita k léčení pouze jednoho bulbu a tento bulbus byl následně enukleován. Záchovná léčba byla tedy úspěšná u sedmi bulbů ze šestnácti postižených, tedy ve 43,75 %.

Eighteen patients suffering of retinoblastoma during three years period (1999- 2001) were treated in two departments of ophthalmology in the Czech Republic. In four cases, the involvement was bilateral. In six eyes, because of very late stage of the disease at the time of diagnosis, the initial treatment was the enucleation. The rest, (sixteen eyes) was treated by chemoreduction (chemotherapy) and different combinations of local therapeutic methods according to their respective findings. Nine eyes from this cohort were enucleated in different period of time after the beginning of the treatment because of the relapse of the disease, its continuing or complications of the treatment. In the remaining seven eyes there are no sings of tumor activity. The fractioned radiotherapy was used in the treatment in one eye only and this eye was enucleated subsequently. So the maintaining therapy was successful in seven eyes of sixteen involved, or in 43.75% of cases.

• MeSH
• Child MeSH
• Eye Enucleation MeSH
• Research Support as Topic MeSH
• Low-Level Light Therapy MeSH
• Humans MeSH
• Eye Neoplasms etiology   therapy   MeSH
• Child, Preschool MeSH
• Antineoplastic Agents pharmacology   therapeutic use   MeSH
• Radiosurgery MeSH
• Radiotherapy MeSH
• Retinoblastoma etiology   therapy   MeSH
• Check Tag
• Child MeSH
• Humans MeSH
• Male MeSH
• Child, Preschool MeSH
• Female MeSH
• Publication type
• Review MeSH
• Comparative Study MeSH

• MeSH
• Radiotherapy Dosage methods   MeSH
• Humans MeSH
• Lung Neoplasms radiotherapy   MeSH
• Radiography MeSH
• Tomography MeSH
• Check Tag
• Humans MeSH